AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PMV Pharmaceuticals, Inc. Director's Dealing 2024

Sep 12, 2024

34350_dirs_2024-09-12_b1d91503-fb93-45ac-aa3f-b7b3b2787dd8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PMV Pharmaceuticals, Inc. (PMVP)
CIK: 0001699382
Period of Report: 2024-09-11

Reporting Person: Carulli Michael (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-09-11	Common Stock	S	2891	$1.5036	Disposed	88395	Direct

Footnotes

F1: These reported shares were sold to cover the reporting person's tax obligation in connection with the vesting of restricted stock units, or RSUs.